Erratum to: A phase 1b study of Selumetinib in combination with Cisplatin and Gemcitabine in advanced or metastatic biliary tract cancer: the ABC-04 study
Name:
art%3A10.1186%2Fs12885-016-240 ...
Size:
333.1Kb
Format:
PDF
Description:
Open access full text article
Authors
Bridgewater, JLopes, A
Beare, S
Duggan, M
Lee, D
Ricamara, M
McEntee, Delyth
Sukumaran, A
Wasan, H
Valle, Juan W
Affiliation
UCL Cancer Institute, 72 Huntley St, London, WC1E 6DD, UKIssue Date
2016
Metadata
Show full item recordCitation
Erratum to: A phase 1b study of Selumetinib in combination with Cisplatin and Gemcitabine in advanced or metastatic biliary tract cancer: the ABC-04 study. 16 (1):369 BMC CancerJournal
BMC CancerDOI
10.1186/s12885-016-2403-1PubMed ID
27328670Type
Meetings and ProceedingsLanguage
enISSN
1471-2407ae974a485f413a2113503eed53cd6c53
10.1186/s12885-016-2403-1
Scopus Count
Collections
Related articles
- A phase 1b study of Selumetinib in combination with Cisplatin and Gemcitabine in advanced or metastatic biliary tract cancer: the ABC-04 study.
- Authors: Bridgewater J, Lopes A, Beare S, Duggan M, Lee D, Ricamara M, McEntee D, Sukumaran A, Wasan H, Valle JW
- Issue date: 2016 Feb 24
- Randomised, Phase II study of selumetinib, an oral inhibitor of MEK, in combination with cisplatin and gemcitabine chemotherapy for patients with advanced biliary tract cancer.
- Authors: Doherty MK, Tam VC, McNamara MG, Jang R, Hedley D, Chen E, Dhani N, Tang P, Sim HW, O'Kane GM, DeLuca S, Wang L, Pedutem T, Knox JJ
- Issue date: 2022 Nov
- A Phase Ib Study of NUC-1031 in Combination with Cisplatin for the First-Line Treatment of Patients with Advanced Biliary Tract Cancer (ABC-08).
- Authors: McNamara MG, Bridgewater J, Palmer DH, Faluyi O, Wasan H, Patel A, Ryder WD, Barber S, Gnanaranjan C, Ghazaly E, Evans TRJ, Valle JW
- Issue date: 2021 Apr
- SELECT-3: a phase I study of selumetinib in combination with platinum-doublet chemotherapy for advanced NSCLC in the first-line setting.
- Authors: Greystoke A, Steele N, Arkenau HT, Blackhall F, Md Haris N, Lindsay CR, Califano R, Voskoboynik M, Summers Y, So K, Ghiorghiu D, Dymond AW, Hossack S, Plummer R, Dean E
- Issue date: 2017 Sep 26
- Cediranib or placebo in combination with cisplatin and gemcitabine chemotherapy for patients with advanced biliary tract cancer (ABC-03): a randomised phase 2 trial.
- Authors: Valle JW, Wasan H, Lopes A, Backen AC, Palmer DH, Morris K, Duggan M, Cunningham D, Anthoney DA, Corrie P, Madhusudan S, Maraveyas A, Ross PJ, Waters JS, Steward WP, Rees C, Beare S, Dive C, Bridgewater JA
- Issue date: 2015 Aug